Stocks · Health care · Pharmaceutical Preparations

Alkermes plc.

ALKS Clue Score59
Ireland Fiscal year ends December CIK 0001520262 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

By person

16 insiders · 33 transactions
50.8×

Richard F. Pops holds 50.8 times base salary in stock. $63.61M of shares against $1.25M in salary for 2025.

Salary from the company's own proxy. The shares are what Richard F. Pops last reported holding, valued at $46.17, the price Ordinary Shares was last bought or sold at on the open market here, on 3 Nov 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Craig C. Hopkinson
EVP R&D, Chief Medical Officer
—
$3.38M (14) scheduled
−$3.38M
65,389
0.0390%
$3.02M
−40.4%
nancy lynn MD snyderman
Director
—
$2.24M (1) scheduled
−$2.24M
15,395
0.0092%
$710.79K
+231.9%
Shane Cooke
Director
—
$2.12M (2) scheduled
−$2.12M
106,679
0.0636%
$4.93M
+6.8%
Samuel Joseph Parisi
VP, Finance (Interim PAO)
—
$888.82K (2) scheduled
−$888.82K
7,717
0.0046%
$356.29K
0.0%
David Joseph Gaffin
EVP, CLO, Alkermes, Inc.
—
$829.29K (10) scheduled
−$829.29K
219,353
0.1308%
$10.13M
+32.2%
Christian Todd Nichols
SVP, Chief Commercial Officer
—
$552.94K (3) scheduled
−$552.94K
102,193
0.0609%
$4.72M
+55.0%
Christopher I Wright
Director
—
$90.20K (1) scheduled
−$90.20K
25,680
0.0153%
$1.19M
+78.1%
Richard F Pops
Director and CEO, Alkermes plc
—
—
—
1,377,740
0.8212%
$63.61M
+16.8%
Blair Curtis Jackson
President & CEO, Alkermes plc
—
—
—
241,308
0.1438%
$11.14M
+52.9%
Iain Michael Brown
SVP, Chief Financial Officer
—
—
—
148,196
0.0883%
$6.84M
+27.4%
Brian P McKeon
Director
—
—
—
38,536
0.0230%
$1.78M
+38.7%
Frank Anders Wilson
Director
—
—
—
35,751
0.0213%
$1.65M
+43.0%
Richard Gaynor
Director
—
—
—
35,751
0.0213%
$1.65M
+43.0%
Cato T Laurencin
Director
—
—
—
33,769
0.0201%
$1.56M
+70.5%
Nancy Lurker
Director
—
—
—
18,222
0.0109%
$841.31K
—
Joshua Reed
SVP, Chief Financial Officer
—
—
—
5,095
0.0030%
$235.24K
—